Senior insider sale
ZENTALIS PHARMACEUTICALS, INC. — senior position signals high conviction
$50.3K
29.25K shares
What this filing means
GALLAGHER CAM plans to sell 29.25K shares of ZENTALIS PHARMACEUTICALS, INC. valued at approximately $50.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/11/2025ACC: 0001725160-25-000045
Director
Since Apr 2020
29.25K
Shares to sell
$50.3K
Approx. market value
687.00
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Release
NA
2/10/2025
687.00Total acquired687.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/10/2025 | Restricted Stock Unit Release NA | 687.00 | — |
| Total | 687.00 | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
28.56K
Market value
$48.9K
2/3/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
687.00
Market value
$1.4K
2/11/2025
Total
Units
29.25K
Value
$50.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/3/2025 | 28.56K | $48.9K | — | Completed |
| Planned — Approximate Date | ||||
2/11/2025 | 687.00 | $1.4K | NASDAQ | Planned |
| Total | 29.25K | $50.3K | ||